Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis

Pool Corporation Announces Increase in Share Repurchase Program, Growth of Quarterly Dividend and Results of 2026 Annual Meeting of Stockholders

Alkami Announces First Quarter 2026 Financial Results

Ethan Allen Reports Fiscal 2026 Third Quarter Results; Strong Operating Cash Flow and Robust Balance Sheet Despite Impact from Macroeconomic Challenges; Declares Regular Dividend

Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast

Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026

MediaAlpha Announces First Quarter 2026 Financial Results

Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Viasat Confirms Successful Launch and Initial Signal Acquisition of ViaSat-3 F3

BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

Climb Global Solutions Reports First Quarter 2026 Results

Aflac Incorporated Announces First Quarter 2026 Results

Neurocrine Biosciences Announces Publication Establishing Clinically Meaningful Improvement Threshold for the Tardive Dyskinesia Impact Scale

California Water Service Group Board of Directors Declares 325th Consecutive Quarterly Dividend

Teladoc Health Reports First Quarter 2026 Results

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K

Beyond Meat® to Report First Quarter 2026 Financial Results on May 6, 2026